The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting tumor-associated macrophage (TAM) mediated inhibition of T-cell migration in prostate cancer using epigenetic modifying agents.
 
David Kosoff
No Relationships to Disclose
 
Leigh Ellis
No Relationships to Disclose
 
David J. Beebe
Employment - Salus Discovery
Leadership - Lynx Biosciences; Onexio Biosystems; Salus Discovery
Stock and Other Ownership Interests - Bellbrook labs; Lynx Biosciences; Onexio Biosystems; Salus Discovery; Stacks to the Future; Turba
Consulting or Advisory Role - Abbott Laboratories; Salus Discovery
Patents, Royalties, Other Intellectual Property - Onexio Biosystems; Salus Discovery; Stack to the future
Travel, Accommodations, Expenses - Abbott Laboratories; Lynx Biosciences; Onexio Biosystems; Salus Discovery
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - Immunomedics; Janssen; Sanofi; Sanofi
Research Funding - Agensys (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.